Allergy Immunotherapy Market

By Treatment;

Subcutaneous Therapy (SCIT) and Sublingual Therapy (SLIT)

By Allergy Type;

Allergic rhinitis, Allergic conjunctivitis, Allergic asthma, Stinging insect venom and Others

By Distribution Channel;

Hospital Pharmacies and Retail Pharmacies & Online Pharmacies

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn119375779 Published Date: June, 2025 Updated Date: August, 2025

Allergy Immunotherapy Market Overview

Allergy Immunotherapy Market (USD Million)

Allergy Immunotherapy Market was valued at USD 3,871.74 million in the year 2024. The size of this market is expected to increase to USD 7,593.07 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.1%.


Allergy Immunotherapy Market

*Market size in USD million

CAGR 10.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)10.1 %
Market Size (2024)USD 3,871.74 Million
Market Size (2031)USD 7,593.07 Million
Market ConcentrationLow
Report Pages355
3,871.74
2024
7,593.07
2031

Major Players

  • Merck
  • Heska
  • Biodiagnostic
  • ALK
  • Allergan plc.
  • Sallergenes Greer

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Allergy Immunotherapy Market

Fragmented - Highly competitive market without dominant players


The Allergy Immunotherapy Market is showcasing impressive growth fueled by rising adoption of desensitization treatments and clinician-guided therapy plans. Nearly 60% of allergy specialists now offer immunotherapy as a primary option, reflecting strong patient and provider confidence. This surge presents clear opportunities for developers of sublingual tablets, accelerated build-up protocols, and customizable allergen extracts. Enhanced professional training and guideline awareness are promoting broader expansion across allergy clinics and primary care settings. This coordinated push is driving increased market visibility and patient outcomes.

Innovative Delivery Systems Transforming Care
Recent technological advancements feature micro-dosing sublingual tablets, rapid build-up schedules, and precision allergen mixtures tailored to specific sensitivities. Approximately 65% of new products aim to streamline treatment duration and reduce side effects. These upgrades are enhancing treatment adherence and improving immunological outcomes. As clinicians adopt these formats, patient retention is rising—further reinforcing market expansion.

Strategic Awareness Campaigns Amplifying Reach
Manufacturers and providers deploy strategies including allergy season educational drives, payer reimbursement tools, and digital symptom tracking apps. As a result, approximately 70% of ENT and allergy clinics now offer structured immunotherapy packages. These measures ease patient onboarding, build trust, and promote continuity of care. Integration of telehealth support and reminder systems further enhances adherence and encourages broader expansion.

Smart Digital Support Driving the Future
The future outlook centers on innovation in connected immunotherapy—such as app-based dosing support, wearable pollen exposure monitors, and AI-driven response tracking. Over 75% of new immunotherapy solutions include digital interfaces for personalized treatment guidance. These technological advancements will offer data-driven treatment adjustments, improved patient engagement, and measurable long-term gains. As these tools become mainstream, the market is set for enduring growth and deeper expansion in allergy care ecosystems.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Treatment
    2. Market Snapshot, By Allergy Type
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By Region
  4. Allergy Immunotherapy Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Allergy Prevalence
        2. Demand for Long-term Relief
        3. Advancements in Biotechnology
        4. Patient Preference
      2. Restraints
        1. Cost of Treatment
        2. Safety Concerns
        3. Lengthy Treatment Duration
        4. Limited Access
      3. Opportunities
        1. Expansion in Emerging Markets
        2. Personalized Medicine Approaches
        3. Technological Innovations
        4. Combination Therapies
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Allergy Immunotherapy Market, By Treatment, 2021 - 2031 (USD Million)
      1. Subcutaneous Therapy (SCIT)
      2. Sublingual Therapy (SLIT)
    2. Allergy Immunotherapy Market, By Allergy Type, 2021 - 2031 (USD Million)
      1. Allergic rhinitis
      2. Allergic conjunctivitis
      3. Allergic asthma
      4. Stinging insect venom
      5. Others
    3. Allergy Immunotherapy Market, By Distribution Channel, 2021 - 2031 (USD Million)

      1. Hospital Pharmacies

      2. Retail Pharmacies & Online Pharmacies

    4. Allergy Immunotherapy Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Merck
      2. Heska
      3. Biodiagnostic
      4. ALK
      5. Allergan plc.
      6. Sallergenes Greer
  7. Analyst Views
  8. Future Outlook of the Market